| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |